Glycopeptides susceptibility among enterococci isolated from a poultry farm in São Paulo, Brazil (1996/1997)

Brazilian Journal of Microbiology

Volumn 31, Issue 1, 2000, Pages 53-57

  Leme, Ivani Lúcia ^a,c   Ferreira, Antonio José Piantino ^b   Bottino, José Américo ^b   Pignatari, Antonio Carlos C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Rua Napoleão de Barros   (Brazil)

Author keywords

Avoparcin; Enterococcus; Glycopeptides; Resistance; Vancomycin

Indexed keywords

AVES; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; GALLUS GALLUS;

EID: 1642320610     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822000000100013     Document Type: Article

References (34)

1. Aarestrup, F. M.; Ahrens, P.; Madsen, M.; Pallesen, L.; Poulsen, L. and Westh, H. Glycopeptide susceptibility among danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemother., 40(8):1938-1949, 1996.
2. Aarestrup, F.M. Ocurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug Resist., 1:255-7, 1995.
3. Bager F.; Madsen M.; Christensen J. and Aarestrup F. M. Avoparcin used as a growth promoter is associated with the occurence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med., 31(1-2):95-112, 1997.
4. Baptista, M.; Departieu, F.; Courvalin, P. and Arthur, M. Specificity of Induction of Glycopeptide Resistance Genes in Enterococcus faecalis. Antimicrob Agents Chemoter., 40(10):2291-2295, 1996.
5. Bates, J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J. Hosp. Infect., 37(2):89-101, 1997.
6. Bates, J.; Jordens, J. Z. and Griffiths, D. T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal. J. Antimicrob. Chemother., 34:507-516, 1994.
7. Bates, J.; Jordens, Z. and Selkon, J.B. Evidence for animal origin of vancomycin-resistant enterococci. Lancet, 342:490-491, 1993.
8. Barrow, P. Further observations on the effect of feeding diets containing Avoparcin on the excretion of salmonellas by experimentally infected chickens. Epidem. Inf., 102, 239-252, 1989.
9. Bogaard A.E.; London, N.; Driessen, C. and Stobberingh, E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med., 337(21):1558-1559, 1997.
10. Chenoweth, C. and Schaberg, D. The epidemiology of enterococci. Eur. J. Clin. Microbiol. Infect. Dis., 9:80-89, 1990.
11. Cormican, M. G.; Erwin, M. and Jones, R. Avoparcin, a glycopeptide used in animal foods:antimicrobial spectrum and potency tested against human isolates from the United States. Diagn. Microbiol. Infect. Dis., 29:241-248, 1997.
12. Das, I.; Fraise, A. and Wise, R. Are glycopeptide-resistant enterococci in animal a threat to human beings? Lancet, 349:9057, 1997.
13. Devriese, L. A.; Bruno, P; Van Damme, L.; Kersters, K. and Haesebrouck, F. Identification of Enterococcus species isolated from foods of animal origin. Int. J. Food Microbiol., 26:187-197, 1995.
14. Donnely, J. P.; Voss, A.; Witte, W. and Murray, B.E. Reply to: Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? [letter] J. Antimicrob. Chemother., 37:390-392, 1996.
15. Facklam, R. and Collins, M.DIdentification of Enterococcus species isolated from humam infections by a conventional test scheme. J. Clin. Microbiol., 27:731-4, 1989.
16. Facklam, R. and Sahm, D.A. Enterococcus. In: A. Ballows (editor), Manual of Clinical Microbiology. American Society for Microbiology, Washington, DC, 1995, p. 308-314.
17. Felmingham, D.; Brown, D.F. and Soussy, C.J. European Glycopeptide Susceptibility survey of Gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. Diag. Microbiol. Infect. Dis., 31(4):563-71, 1998.
18. Frieden, T. R., S. S. Munsiff, D. E.Low, B. M. Willey, G. Williams, Y. Faur, W. Eisner, S. Warren, and B. Kreiswirth. Emergence of vancomycin-resistant enterococci in New York city. Lancet, 342:76-79, 1993.
19. Jeffries, L.; Coleman, K. and Bunyan, J. Antimicrobial substances and chick growth promotion: comparative studies on selectd compounds in vitro and in vivo. Br. Poult. Sci., 18:295-308, 1977.
20. Jordens, J. Z.; Bates, J. and Griffiths, D. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother., 34:515-528, 1994.
21. Kaukas, A.; Hinton, M. and Linton, A. H. The effect of ampicillin and tylosin on the faecal enterococci of healthy young chickens. J. Appl. Bacteriol., 62:441-7, 1987.
22. Klare, I.; Heier, H.; Claus, H.; Reissbrodt, R and Witte, W. vanA-mediated high-level glycopeptide in Enterococcus faecium from animal husbandry. FEMS Microbiol. Letter, 125:165-172, 1995.
23. Knudtson, L. M.; Hartman, P. Routine procedures for isolation nad identification of enterococci and fecal streptococci. Appl. Environ. Microbiol., 58(9) 3027-3031, 1992.
24. Kruse, H. and Rorvik, L. M. The use of avoparcin as a growth promoter and the ocorrence of vancomycin resistant Enterococcus spp. in poultry production [abstract] In: Program and Abstracts of the 96th General Meeting of the American society for Microbiology, New Orleans. American Society for Microbiology; Washington DC, 1996, p 36.
25. Landman, D.; Quale, J.M.; Oydna, E.; Willey, V.; Ditore, M.; Zaman, M.; Patel, K.; Saurina, G. and Huang, W. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J. Clin. Microbiol., 34(3):751-752, 1996.
26. McDonald, L.C.; Kuechnert, J.; Tenover, F. C.; Jarvis, W. Vancomycin-Resistant Enterococci Outside the Health-Care Setting: Prevalence, sources, and Public Health Implications. Emerging Infectious Diseases EID V3N3, Center for Disease Control and Prevention, Atlanta, Georgia, 1997.
27. Murray, B.E. Editorial Response: What Can We Do About Vancomycin-Resistant Enterococci? Clin. Infect. Dis., 20:1134-6, 1995.
28. Murray, B.E. The life and times of the Enterococcus. Clin. Microbiol. Rev., 3:46-65; 1990.
29. National Committee For Clinical Laboratory Standards (NCCLS. Approved standard M7-A3: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3th ed. Villanova, PA, 1993a.
30. National Committee For Clinical Laboratory Standards (NCCLS). Approved standard M2-A5: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Villanova, PA, 1993b.
31. Swenson, J.M. Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J. Clin. Microbiol., 33:3019-3021, 1995.
32. Thal, L.; Chow, J. W.; Mahayni, R.; Bonilla, H.; Perri, M. B.; Donabedian, S.; Silverman, J.; Taber, S.and Zervos, M. Characterization of Antimicrobial Resistance in Enterococci of Animal Origin. Antimicrob. Agents Chemother., 39(9):2112-2115, 1995.
33. Vilins, M.; Valdetaro, F.; Blecher, S.; Pignatari, A.C.; Medeiros, E. A.; Zanella, R.C.; Brandileone, M.C.C.; Nascimento, A. B. G. and Salomão, R. Prevalência de Enterococcus resistente à vancomicina (VRE) em hospital de grande porte na região metropolitana de São Paulo. VI Congresso Brasileiro de Controle de Infecção e Epidemiologia Hospitalar, Campos de Jordão, São Paulo, Brazil. Abstract 02 - Microbiologia, 1998, p. 203.
34. Zanella, R.C.; Valdetaro, F.; Lovgren, M.; Tyrrel, G.; Bokermann, S.; Almeida, s.; Vieira, v.; Brandileone, M.C. First confirmed case of a Vancomycin-resistant enterococcus faecium with vanA phenotipe from Brazil: Isolation from a meningitis case in São Paulo. Microb. Drug Resistance, 5(2), 159-162, 1999.